title: Current and new antitumor necrosis factor agents in perspective.
authors.affiliation: Kennedy Institute of Rheumatology, Imperial College of Science, Technology and Medicine, London, UK. r.maini@imperial.ac.uk
authors.forename: Ravinder N
authors.initials: RN
authors.lastname: Maini
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D014409:Tumor Necrosis Factor-alpha